Cargando…
Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review
BACKGROUND: Gliomas are the most common and aggressive tumors of the central nervous system. A robust and widely used blood-based biomarker for glioma has not yet been identified. In recent years, a plethora of new research on blood-based biomarkers for glial tumors has been published. In this revie...
Autores principales: | Ali, Hamza, Harting, Romée, de Vries, Ralph, Ali, Meedie, Wurdinger, Thomas, Best, Myron G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211985/ https://www.ncbi.nlm.nih.gov/pubmed/34150629 http://dx.doi.org/10.3389/fonc.2021.665235 |
Ejemplares similares
-
Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment
por: Fu, Zaixiang, et al.
Publicado: (2022) -
Blood platelets as an RNA biomarker platform for neuro-oncological diseases
por: Post, Edward, et al.
Publicado: (2022) -
SPAG5 Is Involved in Human Gliomagenesis Through the Regulation of Cell Proliferation and Apoptosis
por: Wang, Chunhong, et al.
Publicado: (2021) -
The Role of Hyperexcitability in Gliomagenesis
por: Goethe, Eric A., et al.
Publicado: (2023) -
Liquid biopsies in patients with diffuse glioma
por: Best, Myron G., et al.
Publicado: (2015)